Rural-urban disparities in cancer outcomes recede for patients enrolled in clinical trials, a new study in JAMA Network Open finds.
On July 6, 2018, Politico reported that top advisers at the U.S. Environmental Protection Agency were suppressing a federal report on the health risks of formaldehyde. The article suggests these advisers are bending to industry interests opposed to the release of the report, which purportedly links formaldehyde exposure to the risk of developing leukemia.
Many hair products used by black women and children contain chemicals that can interfere with the body’s natural hormones, though the majority of these chemicals are not listed on their labels, according to new research forthcoming in the journal Environmental Research.
Two studies published in the Journal of Clinical Oncology in January 2018 probed the same question: Which factors are the main contributors to disparities in cancer survival?
Thirty percent of surveyed women with breast cancer reported skipping additional treatment following surgery.
Globally, lung cancer is the leading cause of cancer-related death, and recently surpassed heart disease as the leading cause of smoking-related mortality. The National Cancer Institute estimates that this year in the U.S., more than 222,000 men and women will be diagnosed with the disease and 157,300 will die. The high mortality rate is in part a consequence of the difficulty in diagnosing the disease. Using chest X-rays, physicians typically discover lung cancers only at an advanced stage.
When cancer is caught early, it is easier and cheaper to treat. The Affordable Care Act (ACA), also known as Obamacare, sought to help Americans catch the disease early by requiring insurers to pay for some types of preventative care as well as an annual checkup.